About

Daniel P. O'Day has served as Chairman and Chief Executive Officer of Gilead Sciences since 2019. Before joining Gilead he spent a more than 30-year career at Roche, most recently as Chief Executive Officer of Roche Pharmaceuticals and a member of Roche's Corporate Executive Committee, holding executive positions across the pharmaceutical and diagnostics divisions in North America, Europe and Asia.

Roles

Gilead Sciences, Inc.
Chairman and Chief Executive Officer · Current role
2019–present

Also at Gilead Sciences, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.